INTRODUCTION
Blood-sucking animals have developed a sophisticated array of salivary antihaemostatic compounds to counteract their host's defence against blood loss. Indeed, anti-clotting, anti-platelet and vasodilatory substances have been characterized in various arthropods, nematodes and vampire bats [1] [2] [3] [4] [5] ). Anti-clotting agents have been recognized in the salivary glands of bloodfeeding ticks and insects for about 80 years [6] , but only more recently a few of these compounds have been characterized biochemically from organisms such as leeches [7] [8] , Ancylostoma hookworms [9] , the soft tick Ornithodorus moubata [10] [11] , the blackfly Simmulium vittatum [12] and the triatomine bug Rhodnius prolixus [13] .
Hellmann and Hawkins [14] have identified and named two anti-clotting activities from the blood-sucking bug R. prolixus. Prolixin S was postulated to be an anti-(Factor VIII) and found in salivary glands, and prolixin G, a thrombin inhibitor found in the anterior midgut of the insect. Recently Friedrich et al. [13] have purified and cloned a thrombin inhibitor found in wholebody homogenates of R. prolixus. Although Friedrich et al. [13] presumed a salivary origin for this inhibitor, it is possible that it represented the purification of prolixin G and not prolixin S, if not from foreign source, since whole blood-fed insects were used.
According to Hellmann and Hawkins [14] , prolixin S did not retard a one-stage prothrombin time, and greatly increased the kaolin/cephalin time, suggesting its action was before Factor Xa activation in the intrinsic pathway. The effect of salivary homogenates did not differ according to whether they were added before or after activation of the contact factors in the kaolin/ cephalin assay, excluding effect on Factors XI and XII. Finally, reconstitution assays with Factor VIII-or IX-deficient plasmas indicated that the main activity of prolixin S was on Factor VIII. Evidence for the protidic nature of prolixin S was given by its sensitivity to trypsin and precipitation by acetone. No further characterization of prolixin S was pursued.
Chem. 270, in the press]. To exclude the possibility of the nitrophorin being a contaminant, another chromatographic protocol was performed, consisting of chromatofocusing followed by strong-cation-exchange chromatography. Again the anticoagulant was eluted with nitrophorin 2. Nitrophorin 2 inhibits coagulation Factor VIII-mediated activation of Factor X and accounts for all the anti-clotting activity observed in Rhodnius salivary glands.
In the present study we purified and obtained the partial sequence of prolixin S. The pure salivary anti-clotting substance is a salivary haem protein formerly identified as nitrophorin 2 [15] , which inhibits the action of Factor VIII activity and shows no sequence similarity to the thrombin inhibitor isolated by Friedrich et al. [13] .
MATERIAL AND METHODS Insect rearing R. prolixus was reared and maintained in the central insectary facility of the Center for Insect Sciences. All instars fed on an anaesthetized rabbit. Salivary glands from unfed fifth-instar nymphs were dissected under PBS [10 mM sodium phosphate (pH 7.0)/150 mM NaClI], transferred to 1.5 ml conical plastic tubes containing 100 ,1l of 10 mM Tris/HCl, pH 7.4, and stored, usually 100 pairs/vial, at -75°C until needed. Salivary homogenates were prepared by homogenizing the glands in the conical tubes by using a plastic pestle (Kontes pellet pestle, obtained from Fisher Scientific, Pittsburg, PA, U.S.A.). After centrifugation at 1400 g for 5 min, the supernatant was collected and used for the experiments.
Protein purffication HPLC was performed by using either a CM4000 or CM4100 pump from Thermoseparation Products (Riviera Beach, FL, U.S.A.) and either a SM4000 or a SM4100 dual-wavelength detector from the same company. The detector output was connected to the serial port of a 80286-or a 80386-based microcomputer with math co-processor, and the absorbance recorded 50 times/min with a home-made computer program written in QUICKBASIC. Weak-cation-exchange chromato- the sample to be tested for anti-clotting activity, were mixed for 2 min at 37°C, followed by addition of 50 #1 of pre-warmed (37°C) 25 mM CaCl2. An eight-channel multipipette was used for delivering portions of CaC12. After the 37°C using the apparatus mixer and heating system and absorbance readings at 650 nm taken at 10 s intervals. A fast and sharp increase in the absorbance after a lag phase indicated clotting. We chose the time taken for reaching a 0.1 or 0.05 absorbance value (onset absorbance) as a measure of clotting time, using the 'time to selected absorbance' module included in the instrument's software. With this procedure, all the fractions resulting from a whole chromatographic procedure could be analysed quickly and simultaneously for anti-clotting activity. The aPTT tests were performed according to the method of Proctor and Rapaport [16] using a kaolin suspension in the presence of rabbit brain cephalin (Sigma Diagnostics, St. Louis, MO, U.S.A.) as indicated by the manufacturer, but using the ELISA reader kinetic module described above. To 50,tl of citrated human plasma, 50 ,u of different dilutions of crude salivary homogenates or purified fractions in Hepes/saline buffer (1O mM Hepes/0.15 M NaCl, pH 7.4) were mixed inside the plate wells, which contained 25 1l of kaolin/cephalin mixture (equal volumes of 8 % kaolin/cephalin working suspension in the Hepes/saline buffer). After incubating at 37°C, with shaking for 3 min, 25 1l of pre-warmed (37°C) 50 mM CaCl2 was added by using an eight-channel multipipette. The plate was then shaked once and maintained at 37°C, with the onset absorbance at 0.05 unit. The absorbance readings at 650 nm were recorded at 10 s intervals. For both recalcification and aPTT assays, clotting times were referred to the plasma control samples assayed under the same conditions, but in the absence of salivary homogenates or their purified fractions. One unit of anticoagulant activity was defined as the amount of protein able to double the clotting time of normal plasma controls.
Thrombin and Factor Xa assays
Thrombin-and Factor Xa-inhibiting activity were done with the chromogenic substrates benzoyl-Phe-Val-Arg p-nitroanilide hydrochloride and benzoyl-Ile-Glu-Gly-Arg p-nitroanilide trifluoroacetate (S-2222) respectively, obtained from Calbiochem (San Diego, CA, U.S.A.).
Anti-(Factor Vil) activity
Anti-(Factor VIII) activity was assayed using COATEST Factor VIII kit from Helena Laboratories (Beaumont, TX, U.S.A.), according to the recommendations of the manufacturer. This test measures the activation of Factor X (determined by the chromogenic substrate S-2222) in the presence of Factor IXa, Ca2l, phospholipid and 1-2581 (a thrombin inhibitor), the activation of Factor X being dependent on the amount of added Factor VIII. In the absence of Factor VIII, activation of Factor X is delayed. Whenever needed, platelet-poor human plasma from one of us (J. M. C. R) was used.
RESULTS
Preliminary experiments using whole salivary-gland homogenates Preliminary experiments confirmed previously obtained results [14] Purffication of the salivary gland anti-clotting activity
To purify prolixin S we submitted 100 pairs of homogenized glands (approx. 10 mg of total protein) to chromatography on a weak cation-exchange (WCX) column (Figure la) . A 10 ,ul portion of each fraction were used to assay anti-clotting activity on a recalcification time assay, indicating that fractions eluted between 7 and 9 min contained anti-clotting activity. The two fractions were combined (1 ml), and diluted with water to 2 ml, followed by chromatography in a TSK-DEAE column. A recalcification time assay of 10 4a1 from each fraction indicated further purification of the anti-clotting activity (Figure lb) . The active fractions eluted between 22 and 25 min (1.5 ml) were pooled, satd. (NH4)2SO4 was added to 2 M final concentration, and the fractions subjected to hydrophobic-interaction chromatography (phenyl-TSK gel). Because the high salt content of this column's eluate leads to interference with the clotting assay, we used only 1 ,l from each fraction to locate the anti-clotting activity. Despite a relatively weak signal, the activity was coeluted with the main eluted peak absorbing at 280 nm ( Figure  ic) . Throughout this whole procedure we observed that the anticoagulant activity was co-eluted with a reddish-brown pigment. The anticlotting fractions resulting from the hydrophobicinteraction column displayed the typical spectra of a haem protein (Figure 2 indicated complete identity with the sequence of our previously isolated nitrophorin 2 [15] .
Confirmation of anti-clotting activity of nitrophorin 2 Because the isolated haem protein could be a major contaminant and responsible for the observed anticoagulant activity, we decided to purify the haem proteins following our protocol for nitrophorin purification [15] . A total of 300 pairs of salivary glands were chromatofocused on a Mono P column eluted from pH 8.3 to 7.0. Anticoagulant activity (using 5 ,u of each column fraction/assay) co-eluted with the nitrophorin 2 ( Figure 3 Figure 4 Strong-cation-exchange chromatography of the active material eluted from the chromatofocusing column (shown In Figure 3) The flow rate was 0.5 ml/min, and fractions were collected at 1 min intervals. Absorbance at 280 nm was recorded. A 5 ,ul portion from each fraction was used in the plasma recalcification clotting assay. our recovering only a single major haem-protein peak containing the anticoagulant activity ( Figure 4 ). The N-terminal sequence from ten residues of the pooled fractions from the strong-cationexchange column (after dialysis and freeze-drying) yielded: DCSTNISPKQ a sequence identical with that of the purified anti-clotting peptide obtained by the above procedure. This two-step purification protocol for the salivary anticoagulant led to a higher yield of the activity (58.7 %) when compared with the four-step protocol described above, and a similar purification index of 25 ( YVTHFLDKDPQVTDQYESSFTPR of which the first eight amino acids matched the last eight residues of the 30-amino-acid sequence reported above (singly underlined part of the sequence). Accordingly, the two fragments are tentatively shown as one sequence in Figure 5( Factor VIII, thus confirming its anti-(Factor VIII) activity postulated 30 years ago by Hellmann and Hawkins [14] (Figure  6a ). Accordingly, correction of the clotting time of Factor VIIIdeficient plasma by normal plasma dilutions was consistently inhibited by nitrophorin 2 (Figure 6b) . In order to estimate to whether all the salivary anticoagulant activity in R. prolixus salivary glands could be attributed to nitrophorin 2, a parallel plasma recalcification assay using increasing concentrations of salivary-gland homogenates or nitrophorin 2 was performed ( Figure 7 ). Taking into consideration the molar absorption coefficients for each nitrophorin [15] and the amount of protein estimated by measuring the area under the 280 nm absorption curve of the chromatofocusing column (Figure 3a) for each nitrophorin, we arrived at a total nitrophorin content of 325 pmol per pair of glands, and close to the value of 282 pmol of NO per pair of glands reported previously [17] . Of (Figure 9 ).
DISCUSSION
Purification of the salivary anticoagulant activity of R. prolixus by two independent chromatographic protocols led to the identification of nitrophorin 2 [15] as the anti-(Factor VIII) molecule present in R. prolixus glands. Nitrophorins are ferric haem proteins found in the salivary glands of R. prolixus ( [15, 17] which carry NO from the salivary glands of the bug to the skin of its vertebrate host, accounting for most of the salivary vasodilatory activity found in R. prolixus glands [17] . The role of NO in the anti-clotting activity can be dismissed on the basis of the fact that the purified haem protein has no bound NO, as shown by the Soret absorption band of the purified protein [15, 17] , as well as the lack of activity of the other haem proteins.
It is interesting to note the acquisition of multiple functions in nitrophorins. Recently we described the antihistamine activity of nitrophorins [17] , another function that might help R. prolixus to feed. Indeed the order Hemiptera (bugs) is evolutionarily old, having appeared at the Carboniferous period. Rhodnius and its ancestors may have been in the habit of blood feeding on reptiles much before mammals appeared (50 million years ago), giving ample time to accumulate multiple functions in proteins that are important in the process of obtaining a blood meal.
The anti-(Factor VIII) activity of nitrophorin 2 may reside in a relatively small stretch of the total molecule not related to the NO binding, because the other three nitrophorins in R. prolixus glands do not display anticoagulant activity, but have similar NO-carrying functions. In particular, nitrophorin 3 shows more sequence similarity at the N-terminal end with nitrophorin 2 than to either nitrophorin 1 and nitrophorin 4 [15] , but only nitrophorin 2 displays anti-clotting activity. On the other hand, Factor VIII is a very large protein containing two subunits which interact with Factor IXa, phospholipids and Ca2 , thus behaving as a cofactor to mediate and to enhance the activity of Factor IXa on Factor X to produce Factor Xa [19] . Because nitrophorin 2 does not inhibit thrombin and Factor Xa (Figure 8) [19] . Further characterization of nitrophorin 2 (prolixin S) may yield insights on the molecular organization of the Factor X-activating complex and of the role of Factor VIII in this process. 
